Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency releases best practice guidance on parallel scientific advice with health-technology-assessment bodies 8 Maj 2014NewsCorporateMedicines European Medicines Agency closed 9 May 2014 7 Maj 2014NewsCorporateMedicines Monitoring the safety of medicines: European Medicines Agency presents first report on implementation of pharmacovigilance legislation to the European Commission 2 Maj 2014NewsCorporateMedicines EMA publishes 2013 annual report 30 April 2014NewsCorporate European Medicines Agency closed 1 May 2014 29 April 2014NewsCorporateMedicines 2013 annual report on EudraVigilance: over 1 million adverse reaction reports received and processed 28 April 2014NewsCorporate European Medicines Agency recommends approval of Mekinist for the treatment of melanoma 25 April 2014Press releaseHumanMedicines European Medicines Agency recommends extending use of Nexavar to include treatment of differentiated thyroid cancer 25 April 2014Press releaseHumanMedicines European Medicines Agency recommendation on the use of Linoladiol N and Linoladiol HN estradiol-containing creams 25 April 2014Press releaseHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2014 25 April 2014NewsHuman 1 … 200 201 202 203 204 Page 204 of 384 205 206 207 208 … 384
European Medicines Agency releases best practice guidance on parallel scientific advice with health-technology-assessment bodies 8 Maj 2014NewsCorporateMedicines
Monitoring the safety of medicines: European Medicines Agency presents first report on implementation of pharmacovigilance legislation to the European Commission 2 Maj 2014NewsCorporateMedicines
2013 annual report on EudraVigilance: over 1 million adverse reaction reports received and processed 28 April 2014NewsCorporate
European Medicines Agency recommends approval of Mekinist for the treatment of melanoma 25 April 2014Press releaseHumanMedicines
European Medicines Agency recommends extending use of Nexavar to include treatment of differentiated thyroid cancer 25 April 2014Press releaseHumanMedicines
European Medicines Agency recommendation on the use of Linoladiol N and Linoladiol HN estradiol-containing creams 25 April 2014Press releaseHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2014 25 April 2014NewsHuman